CureOTCD
Help accelerate research to cure paediatric OTCD: Ornithine Transcarbamylase Deficiency.
Our Mission & Vision
Our Mission: Find a cure for early onset Ornithine Transcarbamylase Deficiency (OTCD). Advocate for individualized treatment options beyond standard of care.
Our Vision: Children with OTCD will be diagnosed immediately after birth and treated promptly in accordance to their specific variant so that they can live a healthy life, free from metabolic crises.
Our Values: Our work depends on meaningful collaborations with various stakeholders, innovative approaches to problem-solving, strong leadership and targeted therapies (mutation-specific).
Current Research Focus: please visit our website, or watch our video to learn more about our current research projects that we are investing in, including a drug repurposing study and stem cell therapy approach to cure OTC Deficiency.